|
🐜
|
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
24 auth.
Toni Celià-Terrassa,
Oscar Meca-Cortés,
F. Mateo,
A. Martínez de Paz,
N. Rubio,
Anna Arnal-Estapé,
Brian J. Ell,
R. Bermudo,
Alba Díaz,
Marta Guerra-Rebollo,
...
J. Lozano,
C. Estarás,
Catalina Ulloa,
D. Alvarez-Simon,
J. Milá,
R. Vilella,
R. Paciucci,
M. Martínez-Balbás,
A. G. de Herreros,
R. Gomis,
Yibin Kang,
J. Blanco,
P. Fernandez,
T. Thomson
|
8 |
2012 |
8
🐜
|
|
🐜
|
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues.
22 auth.
M. Martelli,
G. Sozzi,
Luís Hernández,
V. Pettirossi,
A. Navarro,
D. Conte,
P. Gasparini,
F. Perrone,
P. Modena,
U. Pastorino,
...
A. Carbone,
A. Fabbri,
A. Sidoni,
S. Nakamura,
M. Gambacorta,
P. Fernandez,
J. Ramírez,
J. C. Chan,
W. Grigioni,
E. Campo,
S. Pileri,
B. Falini
|
8 |
2009 |
8
🐜
|
|
🐜
|
p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas.
9 auth.
M. Pinyol,
F. Cobo,
S. Beá,
P. Jares,
I. Nayach,
P. Fernandez,
...
E. Montserrat,
A. Cardesa,
E. Campo
|
8 |
1998 |
8
🐜
|
|
🐜
|
miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice
9 auth.
Cyrielle Clapé,
V. Fritz,
C. Henriquet,
F. Apparailly,
P. Fernandez,
F. Iborra,
...
C. Avancès,
S. Culine,
L. Fajas
|
7 |
2009 |
7
🐜
|
|
🐜
|
Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer.
8 auth.
Antonio Isidoro,
Marta Martínez,
P. Fernandez,
A. Ortega,
G. Santamaría,
M. Chamorro,
...
John Calvin Reed,
J. Cuezva
|
7 |
2004 |
7
🐜
|
|
🐜
|
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances.
11 auth.
E. Camacho,
Luís Hernández,
S. Hernández,
F. Tort,
B. Bellosillo,
S. Beá,
...
F. Bosch,
E. Montserrat,
A. Cardesa,
P. Fernandez,
E. Campo
|
7 |
2002 |
7
🐜
|
|
🐬
|
Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin
F. Brûle,
S. Califice,
F. Garnier,
P. Fernandez,
A. Berchuck,
V. Castronovo
|
7 |
2003 |
7
🐬
|
|
🦁
|
Expression of cathepsins B and S in the progression of prostate carcinoma
10 auth.
P. Fernandez,
X. Farré,
A. Nadal,
E. Fernández,
N. Peiró,
Bonnie F. Sloane,
...
G. Shi,
H. Chapman,
E. Campo,
A. Cardesa
|
7 |
2001 |
7
🦁
|
|
🐜
|
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
17 auth.
M. Marín-Aguilera,
J. Codony-Servat,
O. Reig,
J. Lozano,
P. Fernandez,
M. Pereira,
N. Jiménez,
M. Donovan,
P. Puig,
L. Mengual,
...
R. Bermudo,
A. Font,
E. Gallardo,
M. Ribal,
A. Alcaraz,
P. Gascón,
B. Mellado
|
7 |
2014 |
7
🐜
|
|
🐜
|
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
30 auth.
A. Prat,
C. Saura,
T. Pascual,
C. Hernando,
M. Muñoz,
L. Paré,
B. González Farré,
P. Fernandez,
P. Galván,
N. Chic,
X. González Farré,
Mafalda Oliveira,
M. Gil-Gil,
M. Arumí,
N. Ferrer,
...
Á. Montaño,
Y. Izarzugaza,
A. Llombart-Cussac,
R. Bratos,
S. Gonzalez- Santiago,
E. Martínez,
S. Hoyos,
B. Rojas,
J. Virizuela,
V. Ortega,
R. López,
P. Céliz,
E. Ciruelos,
P. Villagrasa,
J. Gavilá
|
7 |
2019 |
7
🐜
|
|
🐜
|
18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
10 auth.
J. Duch,
D. Fuster,
M. Muñoz,
P. Fernandez,
P. Paredes,
M. Fontanillas,
...
Flavia Guzmán,
S. Rubí,
F. Lomeña,
F. Pons
|
6 |
2009 |
6
🐜
|
